While proteasome components have been implicated in immune surveillance, the role of PSMB9, the key subunit of the immunoproteasome, has been studied primarily in specific contexts like NSCLC, with limited systematic analysis of its pan-cancer expression, role in orchestrating tumor immune environment, and functional relevance to immune-mediated therapies. This evidence concerns the gene PSMB9 and neoplasm.